JP2016520636A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520636A5
JP2016520636A5 JP2016517274A JP2016517274A JP2016520636A5 JP 2016520636 A5 JP2016520636 A5 JP 2016520636A5 JP 2016517274 A JP2016517274 A JP 2016517274A JP 2016517274 A JP2016517274 A JP 2016517274A JP 2016520636 A5 JP2016520636 A5 JP 2016520636A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
phenyl
acceptable salt
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016517274A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520636A (ja
JP6396438B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/061501 external-priority patent/WO2014195322A1/en
Publication of JP2016520636A publication Critical patent/JP2016520636A/ja
Publication of JP2016520636A5 publication Critical patent/JP2016520636A5/ja
Application granted granted Critical
Publication of JP6396438B2 publication Critical patent/JP6396438B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016517274A 2013-06-04 2014-06-03 トリアゾール化合物およびガンマセクレターゼモジュレーターとしてのその使用 Expired - Fee Related JP6396438B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1350684-5 2013-06-04
SE1350684 2013-06-04
PCT/EP2014/061501 WO2014195322A1 (en) 2013-06-04 2014-06-03 Triazole compounds and their use as gamma secretase modulators

Publications (3)

Publication Number Publication Date
JP2016520636A JP2016520636A (ja) 2016-07-14
JP2016520636A5 true JP2016520636A5 (2) 2017-06-01
JP6396438B2 JP6396438B2 (ja) 2018-09-26

Family

ID=50896282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016517274A Expired - Fee Related JP6396438B2 (ja) 2013-06-04 2014-06-03 トリアゾール化合物およびガンマセクレターゼモジュレーターとしてのその使用

Country Status (7)

Country Link
US (1) US9718805B2 (2)
EP (1) EP3004080B1 (2)
JP (1) JP6396438B2 (2)
CN (1) CN105263922B (2)
DK (1) DK3004080T3 (2)
ES (1) ES2701810T3 (2)
WO (1) WO2014195322A1 (2)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6887952B2 (ja) 2015-02-25 2021-06-16 プリレニア ニューロセラピューティクス リミテッド 認知機能を改善するため、およびアルツハイマー病を治療するためのプリドピジンの使用
US11471449B2 (en) 2015-02-25 2022-10-18 Prilenia Neurotherapeutics Ltd. Use of pridopidine to improve cognitive function and for treating Alzheimer's disease
US10576125B2 (en) 2016-10-31 2020-03-03 Hough Ear Institute Methods for enhancing synaptogenesis and neuritogenesis
AU2018281330A1 (en) * 2017-06-05 2019-12-19 Case Western Reserve University Compositions and methods for treating alzheimer's disease
CN121202886A (zh) * 2024-06-26 2025-12-26 浙江养生堂天然药物研究所有限公司 杂环类化合物及其用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030312A1 (it) 2003-02-21 2004-08-22 Chiesi Farma Spa Derivati di acidi 2-fenil-2-alchil-acetici per il trattamento della malattia di alzheimer.
AU2004262970B2 (en) 2003-08-07 2010-03-18 Merck Sharp & Dohme Limited Treatment for Alzheimer's disease and related conditions
JP2007513128A (ja) 2003-12-03 2007-05-24 メルク　エンド　カムパニー　インコーポレーテッド アルツハイマー病および関連状態の治療に有用な１−アルキル−３−チオ置換インドール−２−アルキン酸
RU2361872C2 (ru) 2004-05-26 2009-07-20 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Циннамидное соединение
WO2007125364A1 (en) 2006-04-26 2007-11-08 Merck Sharp & Dohme Limited Piperidines and related compounds for treatment of alzheimer’s disease
JPWO2007135969A1 (ja) 2006-05-19 2009-10-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 ウレア系−シンナミド誘導体
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
JP2010518080A (ja) 2007-02-08 2010-05-27 メルク・シャープ・エンド・ドーム・コーポレイション 治療薬
US8252803B2 (en) 2007-02-12 2012-08-28 Merck Sharp & Dohme Corp. Piperidine derivatives
CA2676715A1 (en) 2007-02-12 2008-08-21 Merck & Co., Inc. Piperazine derivatives for treatment of ad and related conditions
EP2166854A4 (en) 2007-06-13 2012-05-16 Merck Sharp & Dohme TRIAZONE DERIVATIVES FOR THE TREATMENT OF MORBUS ALZHEIMER AND RELATED SUFFERINGS
CA2695543A1 (en) 2007-08-06 2009-02-12 Schering Corporation Gamma secretase modulators
US8518975B2 (en) * 2007-09-06 2013-08-27 Merck Sharp + Dohme Corp. Gamma secretase modulators
WO2009087127A1 (en) 2008-01-11 2009-07-16 F. Hoffmann-La Roche Ag Modulators for amyloid beta
JP5328816B2 (ja) 2008-02-22 2013-10-30 エフ．ホフマン−ラ ロシュ アーゲー アミロイドβの調節薬
MX2011004680A (es) 2008-11-06 2011-05-25 Astrazeneca Ab Moduladores de beta amiloide.
AU2009312856A1 (en) 2008-11-10 2010-05-14 F. Hoffmann-La Roche Ag Heterocyclic gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
UY32622A (es) 2009-05-12 2010-12-31 Astrazeneca Ab Nuevos compuestos para el tratamiento de patologías relacionadas con ab(beta)
ES2519565T3 (es) * 2009-07-15 2014-11-07 Janssen Pharmaceuticals Inc. Derivados de triazol e imidazol sustituidos como moduladores de gamma secretasa
TWI468402B (zh) 2009-07-31 2015-01-11 必治妥美雅史谷比公司 降低β－類澱粉生成之化合物
EP2523949B1 (en) * 2010-01-15 2014-08-20 Janssen Pharmaceuticals Inc. Novel substituted triazole derivatives as gamma secretase modulators
US20110190269A1 (en) * 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
TW201206946A (en) 2010-07-15 2012-02-16 Bristol Myers Squibb Co Compounds for the reduction of beta-amyloid production

Similar Documents

Publication Publication Date Title
JP2016520635A5 (2)
JP2016520636A5 (2)
RU2017114355A (ru) Производные нафтиридина в качестве антагонистов альфа v бета 6 интегрина для лечения, в частности, фиброзных заболеваний
JP2017504611A5 (2)
JP2012508734A5 (2)
JP2016516043A5 (2)
JP2014513110A5 (2)
JP2009542716A5 (2)
JO3754B1 (ar) أشكال كريستالين لمثبط أنزيم كيناز تيروسين بروتون
JP2017528503A5 (2)
JP2017528506A5 (2)
JP2010515715A5 (2)
JP2019500352A5 (2)
JP2016538313A5 (2)
HRP20120969T1 (hr) Spoj azola
UA110310C2 (uk) Сполуки n-арилтриазолу як антагоністи рецепторів лізофосфатидної кислоти (lpar)
CL2015000578A1 (es) Compuesto n-(2-(6-fluoro-1-h-indol-3-il)etil)-3-(2,2,3,3-tetrafluoropropoxi)bencilamina o su sal, antagonista del receptor 5-ht6; composicion farmaceutica; uso en el tratamiento de la enfermedad de alzheimer.
SI3050882T1 (en) Piperidin-4-yl azetidine derivatives, as inhibitors of JAK1
ME01462B (me) Vinilindazolilna jedinjenja"
JO3377B1 (ar) مشتقات بيريدينيل وبيريدينيل مندمج
JP2018534286A5 (2)
JP2016513696A5 (2)
PE20160550A1 (es) Formulaciones de (s)-3-(4-((4-(morfolinometil)bencil)oxi)-1-oxoisoindolin-2-il)piperidin-2,6-diona
JP2015522592A5 (2)
JP2015500223A5 (2)